Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.24 - $2.89 $4,712 - $10,982
-3,800 Reduced 12.5%
26,600 $34,000
Q2 2022

Aug 15, 2022

BUY
$1.32 - $2.12 $40,128 - $64,448
30,400 New
30,400 $50,000
Q1 2022

May 16, 2022

SELL
$1.69 - $5.81 $20,449 - $70,301
-12,100 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.09 - $8.67 $49,489 - $104,907
12,100 New
12,100 $64,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $36.8M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.